Mwandishi:
Mhariri:
Imeboreshwa:
ULY CLINIC
ULY CLINIC
28 Februari 2026, 14:16:03
Acute Pyelonephritis
23 Novemba 2020, 12:00:14
Acute pyelonephritis is a bacterial infection of the renal parenchyma and renal pelvis, usually resulting from ascending infection from the lower urinary tract. It represents a severe form of urinary tract infection (UTI) and may lead to sepsis, renal abscess, or permanent renal damage if not promptly treated.
Outpatient therapy is appropriate only for clinically stable women of reproductive age without danger signs. All other patients require referral or hospital admission for parenteral therapy and monitoring.
Risk Factors
Patient-Related Factors
Female sex
Pregnancy
Diabetes mellitus
Immunosuppression
Advanced age
Previous urinary tract infection
Structural and Functional Factors
Urinary tract obstruction
Urolithiasis
Vesicoureteral reflux
Neurogenic bladder
Benign prostatic hyperplasia (BPH)
Iatrogenic Factors
Urinary catheterization
Recent urological procedures
Instrumentation of urinary tract
Causative Organisms
Most infections are caused by gram-negative bacteria:
Escherichia coli (most common)
Klebsiella species
Proteus species
Enterobacter species
Pseudomonas aeruginosa (complicated infections)
Signs and Symptoms
Systemic Symptoms
Fever (>38°C)
Chills and rigors
Malaise
Nausea and vomiting
Local Symptoms
Flank pain
Costovertebral angle tenderness
Abdominal discomfort
Back pain
Lower Urinary Symptoms
Dysuria
Urinary frequency
Urgency
Haematuria
Severe disease may present with:
Hypotension
Confusion
Septic shock
Diagnostic Criteria
Diagnosis is based on:
Fever with flank pain or costovertebral tendernessAND
Evidence of urinary infection
Supportive findings include:
Pyuria
Bacteriuria
Positive urine culture
Danger Signs (Require Referral or Admission)
Pregnancy
Male patients
Children or elderly patients
Persistent vomiting
Dehydration
Sepsis or hypotension
Altered mental status
Renal impairment
Urinary obstruction
Immunocompromised state
Failure of outpatient therapy
Investigations
Mandatory Tests
Urinalysis (pyuria, bacteriuria, haematuria)
Urine culture and sensitivity
Full blood count
Serum creatinine and urea
Additional Investigations
Blood cultures (febrile patients)
Electrolytes
C-reactive protein (CRP)
Imaging (Indicated When)
Poor clinical response after 48–72 hours
Suspected obstruction
Recurrent infection
Severe illness
Imaging options:
Renal ultrasound
CT scan abdomen/pelvis (preferred in complications)
Management
Management depends on severity and patient risk category.
Pharmacological Management
1. Outpatient Treatment
(Stable non-pregnant women without danger signs)
Empirical therapy:
Ciprofloxacin 500 mg orally every 12 hours for 7–14 days
OR
Cefixime 400 mg orally once daily for 10–14 days
Adjust antibiotics according to culture results.
2. Inpatient Treatment
Indications:
Complicated infection
Severe systemic illness
Inability to tolerate oral medication
Initial Parenteral Therapy
Ceftriaxone 1–2 g IV once daily
OR
Ciprofloxacin 400 mg IV every 12 hours
OR
Gentamicin 5–7 mg/kg IV daily (where appropriate)
Switch to oral antibiotics once clinical improvement occurs.
Total treatment duration:10–14 days
Supportive Treatment
Antipyretics (Paracetamol)
Analgesics
Antiemetics
IV fluids for dehydration
Non-Pharmacological Management
Adequate hydration
Bed rest during acute illness
Monitor urine output
Early mobilization after improvement
Removal or replacement of infected catheter if present
Management of Underlying Cause
Relief of urinary obstruction
Treatment of stones
Management of prostate enlargement
Emergency decompression may be required via:
Ureteric stenting
Percutaneous nephrostomy
Referral Criteria
Immediate referral required for:
Suspected urosepsis
Pregnancy
Male patients
Recurrent pyelonephritis
Renal impairment
Obstructive uropathy
Failure to improve within 48–72 hours
Suspected renal abscess
Complications
Urosepsis
Septic shock
Renal abscess
Chronic pyelonephritis
Renal scarring
Acute kidney injury
Papillary necrosis
Prevention
Primary Prevention
Adequate fluid intake
Proper perineal hygiene
Post-coital voiding
Avoid unnecessary catheterization
Secondary Prevention
Early treatment of lower UTIs
Control diabetes mellitus
Correction of urinary obstruction
Regular follow-up in recurrent infections
Patient Education
Patients should be advised to:
Complete prescribed antibiotics fully
Increase fluid intake
Seek care urgently if fever persists
Return immediately if vomiting or worsening pain develops
Avoid self-medication with antibiotics
Prognosis
With early treatment, prognosis is excellent. Delayed or inadequate treatment increases risk of renal damage and systemic sepsis, especially in high-risk populations.
References
European Association of Urology. Guidelines on Urological Infections. 2024.
Gupta K, et al. International clinical practice guidelines for acute pyelonephritis. Clin Infect Dis. 2011;52(5):e103–e120.
Nicolle LE. Urinary tract infections in adults. Lancet. 2019;393:1228–1237.
Hooton TM. Acute uncomplicated urinary tract infection. N Engl J Med. 2012;366:1028–1037.
World Health Organization. Integrated management of bacterial infections. WHO; 2022.
Wagenlehner FME, et al. Pyelonephritis management strategies. Nat Rev Urol. 2020;17:653–664.
Ministry of Health Standard Treatment Guidelines (STG). 2023 Edition.
Imeandikwa:
